Our Team

Working For You

Minas Shirozian

Vice President, IS Solutions

Minas brings 15 years of enterprise software development experience in the pharmaceutical and financial industries to PharmaMetrics. As Vice President of IS Solutions he leads the product management, architecture, development, quality assurance and product release management for the entire PharmaMetrics suite of products.

Prior to joining PharmaMetrics, Minos served as Manager of the LendScape integration team for Ally Financial Inc. (formerly known as GMAC ResCap). His accomplishments include the design and development of an enterprise SOA framework, the B2B integration of various third-party services and establishment of standards, practices, and guidelines for the enterprise integration department.

Minas holds a Bachelor of Science in Business and Administration from Drexel University with a concentration in Management Information Systems and Finance.

  •  “What sets PharmaMetrics apart is the depth and breadth of their true business knowledge.”
            -- Director, Contracts, Top 20 Pharma

  • “PharmaMetrics solutions can either be a complete business solution or independent modules that supplement your current business infrastructure.”
            -- Director, Contracts, Top 20 Pharma

  • “The implementation was easy and I didn’t need any training whatsoever. If you know how to do your job – the system follows your process. You don’t have to change your process to meet the systems needs.”
                -- Director, Corporate Compliance, Dermatological Company

  • “The industry experience and knowledge of their expanded team of experts sets them far apart from other service providers within the industry.”
                -- Director of Contracting, Amarin Pharma Inc.

  • “PharmaMetrics offers the services and software to handle all of our Managed Markets needs from front-end pricing analytics to the ban-end contract administration.”
            -- Sr. Director, Contract Management, Top 10 Pharma

  • “The robust reports generated enable more accurate forecasting and financial analysis.”
            -- Sr. Director, Top 10 Pharma